The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog Sermorelin: Understanding How It Works, Its Uses, and What People Need to Know Nirvanix Health Blog 2023 FDA approvals: unprecedented volume at moderate value